Showing 1 - 5 results of 5 for search 'Marcel Wiesweg', query time: 0.03s Refine Results
  1. 1
    Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression

    Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and... by Anja Welt, Marcel Wiesweg, Sarah Theurer, Wolfgang Abenhardt, Matthias Groschek, Lothar Müller, Jan Schröder, Mitra Tewes, Marco Chiabudini, Karin Potthoff, Agnes Bankfalvi, Norbert Marschner, Martin Schuler, Frank Breitenbücher

    Published 2020-07-01
    Get full text
    Article
  2. 2
    C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

    C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy by Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, Nika Guberina, Christoph Pöttgen, Hubertus Hautzel, Wilfried E. E. Eberhardt, Kaid Darwiche, Dirk Theegarten, Clemens Aigner, Servet Bölükbas, Martin Schuler, Martin Stuschke, Maja Guberina

    Published 2024-06-01
    Get full text
    Article
  3. 3
    Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer

    Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer by Julius Keyl, René Hosch, Aaron Berger, Oliver Ester, Tobias Greiner, Simon Bogner, Jürgen Treckmann, Saskia Ting, Brigitte Schumacher, David Albers, Peter Markus, Marcel Wiesweg, Michael Forsting, Felix Nensa, Martin Schuler, Stefan Kasper, Jens Kleesiek

    Published 2023-02-01
    Get full text
    Article
  4. 4
    Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

    Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition by Maja Guberina, Kaid Darwiche, Hubertus Hautzel, Christoph Pöttgen, Nika Guberina, Thomas Gauler, Till Ploenes, Lale Umutlu, Dirk Theegarten, Clemens Aigner, Wilfried E. E. Eberhardt, Martin Metzenmacher, Marcel Wiesweg, Rüdiger Karpf-Wissel, Martin Schuler, Ken Herrmann, Martin Stuschke

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT by Maja Guberina, Ken Herrmann, Christoph Pöttgen, Nika Guberina, Hubertus Hautzel, Thomas Gauler, Till Ploenes, Lale Umutlu, Axel Wetter, Dirk Theegarten, Clemens Aigner, Wilfried E. E. Eberhardt, Martin Metzenmacher, Marcel Wiesweg, Martin Schuler, Rüdiger Karpf-Wissel, Alina Santiago Garcia, Kaid Darwiche, Martin Stuschke

    Published 2022-10-01
    Get full text
    Article

Search Tools: